Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
37247 | 63 | 34.0 | 90% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
530 | 3 | SPLENECTOMY//COMMON VARIABLE IMMUNODEFICIENCY//IMMUNE THROMBOCYTOPENIA | 19898 |
2067 | 2 | IMMUNE THROMBOCYTOPENIA//IDIOPATHIC THROMBOCYTOPENIC PURPURA//IMMUNE THROMBOCYTOPENIC PURPURA | 5279 |
37247 | 1 | CD109//SYF2//ANTIGEN CD109 | 63 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CD109 | authKW | 10819049 | 40% | 89% | 25 |
2 | SYF2 | authKW | 1731046 | 8% | 71% | 5 |
3 | ANTIGEN CD109 | authKW | 484694 | 2% | 100% | 1 |
4 | BREAST LYMPHOMA MED ONCOL | address | 484694 | 2% | 100% | 1 |
5 | CARCINOGENESI INESE MINIST HLTH BA | address | 484694 | 2% | 100% | 1 |
6 | GPI LINKED MOLECULE | authKW | 484694 | 2% | 100% | 1 |
7 | MP29 | authKW | 484694 | 2% | 100% | 1 |
8 | NOVARTIZ CO | address | 484694 | 2% | 100% | 1 |
9 | P29 SYF2 | authKW | 484694 | 2% | 100% | 1 |
10 | SK MG 1 GLIOBLASTOMA CELLS | authKW | 484694 | 2% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 138 | 25% | 0% | 16 |
2 | Cell Biology | 124 | 24% | 0% | 15 |
3 | Pathology | 118 | 13% | 0% | 8 |
4 | Biochemistry & Molecular Biology | 38 | 24% | 0% | 15 |
5 | Hematology | 21 | 6% | 0% | 4 |
6 | Dermatology | 20 | 5% | 0% | 3 |
7 | Immunology | 17 | 10% | 0% | 6 |
8 | Rheumatology | 16 | 3% | 0% | 2 |
9 | Biophysics | 13 | 6% | 0% | 4 |
10 | Respiratory System | 6 | 3% | 0% | 2 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BREAST LYMPHOMA MED ONCOL | 484694 | 2% | 100% | 1 |
2 | CARCINOGENESI INESE MINIST HLTH BA | 484694 | 2% | 100% | 1 |
3 | NOVARTIZ CO | 484694 | 2% | 100% | 1 |
4 | JIANGSU PROVICE INFORMAT MOL DRUG TARGE | 242346 | 2% | 50% | 1 |
5 | MCGILL SPR MS IL | 242346 | 2% | 50% | 1 |
6 | JONAN WARD | 161563 | 2% | 33% | 1 |
7 | NEUROL DIS CANC | 123043 | 11% | 4% | 7 |
8 | PEOPLES HOSP NANTONG 2 | 121172 | 2% | 25% | 1 |
9 | OTOLARYNGOL ONCOL LARYNGOL | 44061 | 2% | 9% | 1 |
10 | STATE CHEMO BIO SENSING CHEMOMETR | 40389 | 2% | 8% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PATHOLOGY INTERNATIONAL | 4298 | 8% | 0% | 5 |
2 | JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY | 1186 | 2% | 0% | 1 |
3 | CANCER BIOMARKERS | 787 | 2% | 0% | 1 |
4 | EXPERIMENTAL DERMATOLOGY | 740 | 3% | 0% | 2 |
5 | TUMOR BIOLOGY | 707 | 5% | 0% | 3 |
6 | ALLERGOLOGIA ET IMMUNOPATHOLOGIA | 465 | 2% | 0% | 1 |
7 | ONCOTARGET | 352 | 5% | 0% | 3 |
8 | WOUND REPAIR AND REGENERATION | 326 | 2% | 0% | 1 |
9 | JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES | 295 | 2% | 0% | 1 |
10 | THORAX | 271 | 3% | 0% | 2 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CD109 | 10819049 | 40% | 89% | 25 | Search CD109 | Search CD109 |
2 | SYF2 | 1731046 | 8% | 71% | 5 | Search SYF2 | Search SYF2 |
3 | ANTIGEN CD109 | 484694 | 2% | 100% | 1 | Search ANTIGEN+CD109 | Search ANTIGEN+CD109 |
4 | GPI LINKED MOLECULE | 484694 | 2% | 100% | 1 | Search GPI+LINKED+MOLECULE | Search GPI+LINKED+MOLECULE |
5 | MP29 | 484694 | 2% | 100% | 1 | Search MP29 | Search MP29 |
6 | P29 SYF2 | 484694 | 2% | 100% | 1 | Search P29+SYF2 | Search P29+SYF2 |
7 | SK MG 1 GLIOBLASTOMA CELLS | 484694 | 2% | 100% | 1 | Search SK+MG+1+GLIOBLASTOMA+CELLS | Search SK+MG+1+GLIOBLASTOMA+CELLS |
8 | STAT3 AND GLYCOSYL PHOSPHATIDYLINOSITOL ANCHORED PROTEINS | 484694 | 2% | 100% | 1 | Search STAT3+AND+GLYCOSYL+PHOSPHATIDYLINOSITOL+ANCHORED+PROTEINS | Search STAT3+AND+GLYCOSYL+PHOSPHATIDYLINOSITOL+ANCHORED+PROTEINS |
9 | SWATH TM | 484694 | 2% | 100% | 1 | Search SWATH+TM | Search SWATH+TM |
10 | THIOESTER PROTEIN | 484694 | 2% | 100% | 1 | Search THIOESTER+PROTEIN | Search THIOESTER+PROTEIN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ZHANG, JM , MURAKUMO, Y , HAGIWARA, S , JIANG, P , MII, S , KALYONCU, E , SAITO, S , SUZUKI, C , SAKURAI, Y , NUMATA, Y , ET AL (2015) CD109 ATTENUATES TGF-BETA 1 SIGNALING AND ENHANCES EGF SIGNALING IN SK-MG-1 HUMAN GLIOBLASTOMA CELLS.BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. VOL. 459. ISSUE 2. P. 252 -258 | 19 | 70% | 4 |
2 | SAKAKURA, H , MURAKUMO, Y , MII, SJ , HAGIWARA, S , KATO, T , ASAI, M , HOSHINO, A , YAMAMOTO, N , SOBUE, S , ICHIHARA, M , ET AL (2014) DETECTION OF A SOLUBLE FORM OF CD109 IN SERUM OF CD109 TRANSGENIC AND TUMOR XENOGRAFTED MICE.PLOS ONE. VOL. 9. ISSUE 1. P. - | 16 | 64% | 2 |
3 | SAKAKURA, H , MII, S , HAGIWARA, S , KATO, T , YAMAMOTO, N , HIBI, H , TAKAHASHI, M , MURAKUMO, Y , (2016) CD109 IS A COMPONENT OF EXOSOME SECRETED FROM CULTURED CELLS.BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. VOL. 469. ISSUE 4. P. 816 -822 | 18 | 53% | 0 |
4 | SUNAGAWA, M , MII, S , ENOMOTO, A , KATO, T , MURAKUMO, Y , SHIRAKI, Y , ASAI, N , ASAI, M , NAGINO, M , TAKAHASHI, M , (2016) SUPPRESSION OF SKIN TUMORIGENESIS IN CD109-DEFICIENT MICE.ONCOTARGET. VOL. 7. ISSUE 50. P. 82836 -82850 | 18 | 38% | 0 |
5 | HWANG, SM , KIM, MJ , CHANG, HE , HONG, YJ , KIM, TS , SONG, EY , PARK, KU , SONG, J , HAN, KS , (2013) HUMAN PLATELET ANTIGEN GENOTYPING AND EXPRESSION OF CD109 (HUMAN PLATELET ANTIGEN 15) MRNA IN VARIOUS HUMAN CELL TYPES.BIOMED RESEARCH INTERNATIONAL. VOL. . ISSUE . P. - | 11 | 61% | 4 |
6 | ZONG, GJ , XU, ZW , ZHANG, SS , SHEN, YF , QIU, HY , ZHU, GZ , HE, S , TAO, T , CHEN, XD , (2016) CD109 MEDIATES CELL SURVIVAL IN HEPATOCELLULAR CARCINOMA CELLS.DIGESTIVE DISEASES AND SCIENCES. VOL. 61. ISSUE 8. P. 2303 -2314 | 12 | 50% | 0 |
7 | MII, S , MURAKUMO, Y , ASAI, N , JIJIWA, M , HAGIWARA, S , KATO, T , ASAI, M , ENOMOTO, A , USHIDA, K , SOBUE, S , ET AL (2012) EPIDERMAL HYPERPLASIA AND APPENDAGE ABNORMALITIES IN MICE LACKING CD109.AMERICAN JOURNAL OF PATHOLOGY. VOL. 181. ISSUE 4. P. 1180-1189 | 16 | 40% | 1 |
8 | EMORI, M , TSUKAHARA, T , MURATA, K , SUGITA, S , SONODA, T , KAYA, M , SOMA, T , SASAKI, M , NAGOYA, S , HASEGAWA, T , ET AL (2015) PROGNOSTIC IMPACT OF CD109 EXPRESSION IN MYXOFIBROSARCOMA.JOURNAL OF SURGICAL ONCOLOGY. VOL. 111. ISSUE 8. P. 975 -979 | 10 | 50% | 1 |
9 | MII, S , SHIGETOMI, T , YAMAMOTO, N , FURUE, H , UEDA, M , TAKAHASHI, M , HAGIWARA, S , MURAKUMO, Y , (2010) PROCESSING OF CD109 BY FURIN AND ITS ROLE IN THE REGULATION OF TGF-BETA SIGNALING.ONCOGENE. VOL. 29. ISSUE 15. P. 2181 -2191 | 13 | 36% | 20 |
10 | BIZET, AA , TRAN-KHANH, N , SAKSENA, A , LIU, K , BUSCHMANN, MD , PHILIP, A , (2012) CD109-MEDIATED DEGRADATION OF TGF-SS RECEPTORS AND INHIBITION OF TGF-SS RESPONSES INVOLVE REGULATION OF SMAD7 AND SMURF2 LOCALIZATION AND FUNCTION.JOURNAL OF CELLULAR BIOCHEMISTRY. VOL. 113. ISSUE 1. P. 238 -246 | 11 | 38% | 24 |
Classes with closest relation at Level 1 |